sport football: Today’s stock pick update

Kamis, 12 November 2020

Today’s stock pick update – Open Now

The best window to place trades…. possible gains of $24,520 per trade…

To me, there’s no such thing as luck in the stock market. Ever since the discovery of what could be the best window of time to place trades… The COUNTDOWN of the days to the next windfall is here!! Not only that… But using this secret time window on biotech stocks, you could make trades without risking a single penny of your initial stake… And still make up to $24,520 per trade! Life is good… Want in on the secret?(Ad)

Click here to see this secret biotech time window.

Initial Unemployment Claims Fell To Their Lowest Level Since March

Initial unemployment claims fell by the most in five weeks, signaling the gradual recovery in the labor market amid the COVID-19 pandemic is continuing. The Labor Department reported new jobless claims for the week ended November 7 of 709,000, down 48,000 from the week prior. Continuing claims fell by 436,000 to 6.79 million for the week ended October 31, while the number of people claiming support in programs offering extended assistance continued to rise as more Americans e...

Read More

Surface Oncology Inc (NASDAQ: SURF): Surface Oncology shares are up 4% today following yesterday’s announcement that the FDA has granted Fast Track designation to its SRF388 treatment for patients with hepatocellular carcinoma (HCC), or liver cancer. “Liver cancer is the most rapidly increasing type of cancer in both men and women in the U.S., with incidences tripling since 198...

Read More

AT&T’s value has gotten better in the last month

In that vein, I think AT&T Inc. (T) occupies an interesting, if under-appreciated spot in today’s economy. T has, of course long been one of the largest telecommunications companies in the United States, which has also given them the ability to branch out and diversify their business into the entertainment world. In 2015, the company acquired DirecTV, which in the last quarter was a portion of the business that underperformed, f...

Read More

Featured Stock

Surface Oncology, Inc. (SURF) – Buy Price: $10.00 or better

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies. The company develops human immunoglobulin isotype G4 monoclonal antibodies, including SRF231 inhibiting CD47; NZV930 inhibiting CD73; SRF617 inhibiting CD39; SRF388 targeting interleukin 27; and SRF813 targeting CD112R. It also develops various earlier stage programs that targets other critical components of the tumor microenvironment, including regulatory T cells and natural kill...

Read More